Public Health Genomics Knowledge Base (v1.2)
Query Trace: Cancer[orginal query]
Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: American Society of Clinical Oncology Endorsement of Cancer Care Ontario Guideline Recommendations.
Published 2016 ( American Society of Clinical Oncology)
Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.
Published 2015
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.
Published 2016 ( American Society of Clinical Oncology)
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.
Published 2016 ( National Comprehensive Cancer Network)
Singapore Cancer Network (SCAN) Guidelines for Referral for Genetic Evaluation of Common Hereditary Cancer Syndromes.
Published 2016 ( Singapore Cancer Network)
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement.
Published 2016 ( U.S. Preventive Services Task Force)
SEOM clinical guidelines in Hereditary Breast and ovarian cancer.
Published 2015 ( Sociedad Espanola de Oncologia Medica (SEOM))
Recommendations from the EGAPP Working Group: does the use of Oncotype DX tumor gene expression profiling to guide treatment decisions improve outcomes in patients with breast cancer?
Published 2015 ( Evaluation of Genomic Applications in Practice and Prevention)
Recommendations of the Scientific Committee of the Italian Beckwith-Wiedemann Syndrome Association on the diagnosis, management, and follow-up of the syndrome.
Published 2015 ( Italian BWS Association)
Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories.
Published 2015 ( Clinical Sequencing Exploratory Research Consortium)
Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor Markers.
Published 2016 ( European Group on Tumor Markers)
Clinical Practice Guideline for the prevention and early detection of breast and ovarian cancer in women from HBOC (hereditary breast and ovarian cancer) families.
Published 2015 (Expert panel)
SEOM clinical guidelines in early-stage breast cancer 2015.
Published 2015
BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance.
Published 2015 ( Clinical Working Group of ENIGMA)
American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision Making.
Published 2015 ( American Thyroid Association Surgical Affairs Committee)
Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium "Care for CMMR-D" (C4CMMR-D).
Published 2014 (EU-Consortium Care for CMMR-D (C4CMMR-D))
The clinical application of genome-wide sequencing for monogenic diseases in Canada: Position Statement of the Canadian College of Medical Geneticists.
Published 2015 ( Canadian College of Medical Geneticists)
BRCA1 and BRCA2 genetic testing - pitfalls and recommendations for managing variants of uncertain clinical significance.
Published 2015 ( Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group)
Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO).
Published 2014 ( European Society for Medical Oncology (ESMO))
Committee opinion no. 634: hereditary cancer syndromes and risk assessment.
Published 2015 ( American College of Obstetricians and Gynecologists (ACOG) - Committee on Genetics )
Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the U.S. Multi-Society Task Force on Colorectal Cancer.
Published 2014 (U.S. Multi-Society Task Force on Colorectal Cancer)
Japanese Society of Medical Oncology Clinical Guidelines: RAS (KRAS/NRAS) mutation testing in colorectal cancer patients.
Published 2015 ( Japanese Society of Medical Oncology)
Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer.
Published 2015 ( Society of Gynecologic Oncology (SGO))
[2014 update of the GEFPICS' recommendations for HER2 status determination in breast cancers in France].
Published 2014 (GEFPICS)
Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline.
Published 2014 ( American Society of Clinical Oncology)
National Working Group Meeting on ALK diagnostics in lung cancer.
Published 2014 (Pfizer-sponsored National Working Group Meeting on ALK Diagnostics in Lung Cancer)
Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration.
Published 2013 (Expert panel)
ACOG committee opinion no. 527: Personalized genomic testing for disease risk.
Published 2012 ( American College of Obstetricians and Gynecologists (ACOG) - Committee on Genetics)
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
Published 2015 ( American Society of Clinical Oncology (ASCO))
Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline.
Published 2013 ( Endocrine Society)
ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.
Published 2015 ( American College of Gastroenterology)
Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan?
Published 2009 ( Evaluation of Genomic Applications in Practice and Prevention)
Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives.
Published 2009 ( Evaluation of Genomic Applications in Practice and Prevention)
Recommendations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer?
Published 2009 ( Evaluation of Genomic Applications in Practice and Prevention)
Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement.
Published 2012 ( US Preventive Services Task Force)
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.
Published 2012 ( European Society for Medical Oncology)
Final Recommendation Statement: Lung Cancer: Screening, December 2013
Published 2013 ( US Preventive Services Task Force)
Final Recommendation Statement: Breast Cancer: Medications for Risk Reduction, September 2013
Published 2013 ( US Preventive Services Task Force)
Final Recommendation Statement: BRCA-related Cancer: Risk Assessment, Genetic Counseling and Genetic Testing, December 2013
Published 2013 ( US Preventive Services Task Force )
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013.
Published 2013 ( St Gallen International Breast Cancer Conference (2013) Expert Panel)
NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer.
Published 2013 ( National Society of Genetic Counselors)
Intraoperative tests (RD-100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer
Published 2013 ( National Institute for Health and Care Excellence)
Gene expression profiling and expanded immunohistochemistry tests for guiding adjuvant chemotherapy decisions in early breast cancer management: MammaPrint, Oncotype DX, IHC4 and Mammostrat
Published 2013 ( National Institute for Health and Care Excellence)
Familial breast cancer: summary of updated NICE guidance.
Published 2013 ( National Institute for Health and Care Excellence)
Everolimus in combination with exemestane for treating advanced HER2-negative hormone-receptor-positive breast cancer after endocrine therapy
Published 2013 ( National Institute for Health and Care Excellence)
EGFR-TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer
Published 2013 ( National Institute for Health and Care Excellence)
Guideline Recommendations for EGFR Mutation Testing in Lung Cancer: Proposal of the Korean Cardiopulmonary Pathology Study Group.
Published 2013 (Korean Cardiopulmonary Pathology Study Group)
Recommendations from the EGAPP Working Group: can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients with metastatic colorectal cancer improve health outcomes by guiding decisions regarding anti-EGFR therapy?
Published 2013 ( Evaluation of Genomic Applications in Practice and Prevention)
Informing family members of individuals with Lynch syndrome: a guideline for clinical geneticists.
Published 2013 (Dutch Society for Clinical Genetics)
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.
Published 2013 ( College of American Pathologists) ( International Association for the Study of Lung Cancer) ( Association for Molecular Pathology)
Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline.
Published 2013 ( American Society of Clinical Oncology)
Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer.
Published 2014 (US Multi-society Task Force on colorectal cancer)
U.S. Food and Drug Administration approval summary: Erlotinib for the first-line treatment of metastatic non-small cell lung cancer with epidermal growth factor receptor exon 19 deletions or exon 21 (L858R) substitution mutations.
Published 2014 ( US Food and Drug Administration)
[Diagnosis and management of hereditary colorectal cancer according to the JSCCR Guidelines 2012 for the Clinical Practice of Hereditary Colorectal Cancer].
Published 2014 ( Japanese Society for Cancer of the Colon and Rectum)
Recommendations for analyzing and reporting TP53 gene variants in the high-throughput sequencing era.
Published 2014 (Expert group)
Guidance for laboratories performing molecular pathology for cancer patients.
Published 2014 ( European Society of Pathology Task Force on Quality Assurance in Molecular Pathology)
Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update.
Published 2014 ( European Group on Tumor Markers)
Guideline Recommendations for Testing of ALK Gene Rearrangement in Lung Cancer: A Proposal of the Korean Cardiopulmonary Pathology Study Group.
Published 2014 (Cardiopulmonary Pathology Study Group of the Korean Society of Pathologists)
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
Published 2014 ( American Society of Clinical Oncology) ( College of American Pathologists)
Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline
Published 2014 ( American Society of Clinical Oncology)
American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers.
Published 2014 ( American Society of Clinical Oncology)
ACMG technical standards and guidelines for genetic testing for inherited colorectal cancer (Lynch syndrome, familial adenomatous polyposis, and MYH-associated polyposis).
Published 2014 ( American College of Medical Genetics and Genomics)
Endometrial cancer: a review and current management strategies: part I.
Published 2014 ( Society of Gynecologic Oncology Clinical Practice Committee)
Updated UK Recommendations for HER2 assessment in breast cancer.
Published 2015 ( National Coordinating Committee for Breast Pathology)
Lynch Syndrome: A Primer for Urologists and Panel Recommendations.
Published 2015 (Expert Panel)
Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines.
Published 2015 ( American Society of Clinical Oncology (ASCO)) ( European Society for Medical Oncology (ESMO))
A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.
Published 2015 ( American College of Medical Genetics and Genomics) ( National Society of Genetic Counselors)
Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium "Care for CMMR-D" (C4CMMR-D).
Published 2014 (European Consortium "Care for CMMR-D" (C4CMMR-D))
Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO)
Published 2014 ( European Society for Medical Oncology (ESMO))
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.
Published 2014 ( U.S. Preventive Services Task Force)